- ISIN
- US15102K1007
- CUSIP
- 15102K100
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- IPO Date
- Sep 20, 2017
Highlights
- Market Cap
- $4.21B
- Enterprise Value
- $4.26B
- EPS (TTM)
- -$3.81
- Gross Profit (TTM)
- -$41.00K
- EBITDA (TTM)
- -$168.13M
- Year Range
- $38.93 - $151.02
- Target Price
- $151.71
- ROA (TTM)
- -47.03%
- ROE (TTM)
- -360.37%
- Avg. Volume (1M)
- 2M
- Avg. Volume Value (1M)
- $168.28M
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
CELC Performance Chart
Celcuity Inc. (CELC) is down 13.4% since the beginning of the year. At $86 per share, CELC is trading 42.8% below its 52-week high of $151. Investors who bought $1,000 worth of CELC shares 5 years ago would now be looking at an investment worth $4,385.
Loading charts...
Compare this symbol against anything
Returns By Period
Celcuity Inc. (CELC) has returned -13.39% so far this year and 116.44% over the past 12 months.
Celcuity Inc.
- 1D
- -1.44%
- 1M
- -19.98%
- 6M
- -21.06%
- YTD
- -13.39%
- 1Y
- 116.44%
- 3Y*
- 105.46%
- 5Y*
- 34.40%
- 10Y*
- —
- ALL TIME*
- 24.55%
Benchmark (S&P 500 Index)
- 1D
- 0.70%
- 1M
- 0.09%
- 6M
- 7.94%
- YTD
- 9.41%
- 1Y
- 20.07%
- 3Y*
- 17.84%
- 5Y*
- 11.25%
- 10Y*
- 13.26%
- ALL TIME*
- 8.09%
CELC Monthly Returns History
Based on dividend-adjusted daily data since Sep 20, 2017, CELC's average daily return is +0.22%, while the average monthly return is +4.60%. At this rate, an investment would double in approximately 1.3 years.
Historically, 49% of months were positive and 51% were negative. The best month was Jul 2025 with a return of +193.4%, while the worst month was Nov 2019 at -32.1%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 6 months.
On a daily basis, CELC closed higher 49% of trading days. The best single day was Jul 28, 2025 with a return of +167.2%, while the worst single day was Jun 2, 2026 at -25.7%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 9.71% | 2.09% | 2.18% | 6.32% | 9.50% | -21.27% | -17.43% | -13.39% | |||||
| 2025 | -8.71% | -21.09% | 7.21% | 10.19% | -4.58% | 25.59% | 193.37% | 30.81% | -3.57% | 56.19% | 31.08% | -1.38% | 661.96% |
| 2024 | 3.64% | 3.05% | 38.82% | -26.99% | 0.19% | 3.67% | 11.90% | -12.93% | -6.58% | 3.96% | -17.42% | 2.27% | -10.16% |
| 2023 | -31.62% | 22.96% | -12.99% | 0.20% | 5.21% | 1.62% | -10.02% | -3.64% | -3.99% | 16.52% | 37.75% | -0.68% | 4.00% |
| 2022 | -15.69% | -9.17% | -7.43% | -30.27% | 0.31% | 39.14% | -0.22% | 2.97% | 7.38% | -0.40% | -8.60% | 53.28% | 6.22% |
| 2021 | 59.39% | -2.74% | 0.99% | 92.89% | -2.06% | -11.41% | -17.92% | 11.68% | -18.18% | 0.56% | -16.57% | -12.65% | 44.00% |
Benchmark Metrics
Celcuity Inc. has an annualized alpha of 53.81%, beta of 0.84, and R2 of 0.03 versus S&P 500 Index. Calculated based on daily prices since September 20, 2017.
- This stock captured 119.92% of S&P 500 Index gains but only 75.22% of its losses - a favorable profile for investors.
- R2 of 0.03 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 53.81%
- Beta
- 0.84
- R²
- 0.03
- Upside Capture
- 119.92%
- Downside Capture
- 75.22%
Return for Risk
Risk / Return Rank
CELC ranks 85 for risk / return — above 85% of stocks peers on PortfoliosLab. Its historical combined result is among the stronger results in the peer group.
Risk / Return Metrics
The table below present risk-adjusted performance metrics for Celcuity Inc. (CELC) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CELC | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.16 | ||
| Sortino ratioReturn per unit of downside risk | +0.28 | ||
| Omega ratioGain probability vs. loss probability | 1.31 | 1.25 | +0.06 |
| Calmar ratioReturn relative to maximum drawdown | 2.80 | 2.00 | +0.80 |
| Martin ratioReturn relative to average drawdown | 7.33 | 8.49 | -1.16 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Celcuity Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Celcuity Inc. was 85.64%, occurring on Apr 16, 2020. Recovery took 302 trading sessions.
The current Celcuity Inc. drawdown is 40.42%.
Drawdown | Fall | Recovery | Underwater | Related event |
|---|---|---|---|---|
-85.64%Apr 2020 | 1y 6mo | 1y 2mo | 2y 9moSep 2018 - Jun 2021 | COVID crash2020 |
-82.70%May 2022 | 10mo 18d | 3y 2mo | 4y 1moJun 2021 - Jul 2025 | Bear market2022 |
-43.25%Jul 2026 | 2mo 23d | — | 3moMay 2026 - now | — |
-37.41%Mar 2018 | 4mo 7d | 3mo 4d | 7mo 11dNov 2017 - Jun 2018 | — |
-27.68%Oct 2025 | 22d | 19d | 1mo 11dSep 2025 - Oct 2025 | — |
Drawdown Indicators
| CELC | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -85.64% | -56.78% | -28.86% |
Max Drawdown (1Y)Largest decline over 1 year | -43.25% | -9.10% | -34.15% |
Max Drawdown (3Y)Largest decline over 3 years | -61.99% | -18.90% | -43.09% |
Max Drawdown (5Y)Largest decline over 5 years | -76.32% | -25.43% | -50.89% |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -40.42% | -1.58% | -38.84% |
Average DrawdownAverage peak-to-trough decline | -44.81% | -10.70% | -34.11% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 16.51% | 2.14% | +14.37% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Celcuity Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Celcuity Inc. is priced in the market compared to other companies in the Diagnostics & Research industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for CELC in comparison with other companies in the Diagnostics & Research industry. Currently, CELC has a P/B value of 87.9. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with CELC
Add Celcuity Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with CELC